Welcome to Inflection Biosciences

Inflection Biosciences is developing small molecule therapeutics for the treatment of cancer. The company is creating a pipeline of highly innovative cancer treatments through alliances with leading cancer research organisations. The pipeline includes unique dual mechanism kinase inhibitors and PIM kinase inhibitors in preclinical development.

Addressing Unmet Needs

Cancer continues to be a major threat to human health globally. While progress has been made, much more needs to be achieved to provide better treatment solutions for patients. Our research and development focus targets major unmet medical needs in cancer.




Search - Use spaces to separate your keywords
Inflection Biosciences. Suite 15, Anglesea House Carysfort Avenue, Blackrock,  Co. Dublin.  

 Company registration no. 509046.

© 2019 Inflection Biosciences.   Web Design by Webtrade